Molina Healthcare Reports Second Quarter 2024 Financial Results

Reaffirms Full Year 2024 Earnings Guidance

Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported second quarter 2024 GAAP earnings per diluted share of $5.17 and adjusted earnings per diluted share of $5.86. Financial results are summarized below:

 

Three months ended

 

Six months ended

 

June 30,

 

June 30,

 

2024

 

2023

 

2024

 

2023

 

 

 

 

 

 

 

 

(In millions, except per-share results)

Premium Revenue

$

9,446

 

 

$

8,042

 

 

$

18,950

 

 

$

15,927

 

Total Revenue

$

9,880

 

 

$

8,327

 

 

$

19,811

 

 

$

16,476

 

 

 

 

 

 

 

 

 

GAAP:

 

 

 

 

 

 

 

Net Income

$

301

 

 

$

309

 

 

$

602

 

 

$

630

 

EPS – Diluted

$

5.17

 

 

$

5.35

 

 

$

10.33

 

 

$

10.87

 

Medical Care Ratio (MCR)

 

88.6

%

 

 

87.5

%

 

 

88.6

%

 

 

87.3

%

G&A Ratio

 

7.0

%

 

 

7.4

%

 

 

7.1

%

 

 

7.3

%

After-tax Margin

 

3.0

%

 

 

3.7

%

 

 

3.0

%

 

 

3.8

%

 

 

 

 

 

 

 

 

Adjusted:

 

 

 

 

 

 

 

Net Income

$

341

 

 

$

327

 

 

$

675

 

 

$

664

 

EPS – Diluted

$

5.86

 

 

$

5.65

 

 

$

11.59

 

 

$

11.45

 

G&A Ratio

 

6.9

%

 

 

7.4

%

 

 

7.0

%

 

 

7.3

%

After-tax Margin

 

3.5

%

 

 

3.9

%

 

 

3.4

%

 

 

4.0

%

 

 

 

 

 

 

 

 

See the Reconciliation of Unaudited Non-GAAP Financial Measures at the end of this release.

Quarter Highlights

  • As of June 30, 2024, the Company served approximately 5.6 million members, an increase of 8% compared to June 30, 2023.
  • Premium revenue was approximately $9.4 billion for the second quarter of 2024, an increase of 17% year over year.
  • GAAP net income was $5.17 per diluted share for the second quarter of 2024, a decrease of 3% year over year.
  • Adjusted net income was $5.86 per diluted share for the second quarter of 2024, an increase of 4% year over year.
  • The Company reaffirmed its full year 2024 guidance with expected premium revenue of approximately $38 billion and adjusted earnings of at least $23.50 per diluted share.

“We are pleased with our performance in the quarter as our flagship Medicaid business continues to perform well along with strong contributions from both our Medicare and Marketplace businesses,” said Joseph Zubretsky, President and Chief Executive Officer. “We have successfully navigated the unprecedented redetermination process, and these highly attractive businesses provide the foundation for near and long-term sustainable profitable growth.”

Premium Revenue

Premium revenue was approximately $9.4 billion for the second quarter of 2024, an increase of 17% year over year. The higher premium revenue reflects new contract wins, acquisitions, and growth in our current footprint, partially offset by the impact of Medicaid redeterminations.

Net Income

GAAP net income for the second quarter of 2024 was $5.17 per diluted share, a decrease of 3% year over year. Adjusted net income for the second quarter of 2024 was $5.86 per diluted share, an increase of 4% year over year.

Medical Care Ratio (MCR)

  • The consolidated MCR for the second quarter of 2024 was 88.6% and reflects continued focus on managing medical costs.
  • The Medicaid MCR for the second quarter of 2024 was 90.8%. Within that result, approximately 70 basis points were due to a one-time, retroactive premium adjustment related to the prior year. “New store�� Medicaid plans increased the reported MCR by approximately 80 basis points. Excluding the one-time item and new stores, the Medicaid MCR was approximately 89.3% and modestly higher than the Company’s long-term expectations due to redetermination-related acuity shifts.
  • The Medicare MCR for the second quarter of 2024 was 84.9%, better than the Company’s expectations, and reflects favorable risk adjustment results, and benefit adjustments implemented for 2024.
  • The Marketplace MCR for the second quarter of 2024 was 71.6%, better than the Company’s expectations, and reflects the Company’s favorable risk adjustment results.

General and Administrative Expense Ratio

The G&A ratio and the adjusted G&A ratio for the second quarter of 2024 were 7.0% and 6.9%, respectively.

Balance Sheet

Cash and investments at the parent company were $235 million as of June 30, 2024 compared to $742 million as of December 31, 2023.

Days in claims payable at June 30, 2024 was 50.

Cash Flow

Operating cash flow for the six months ended June 30, 2024 was a use of $5 million, compared to $1,403 million for the six months ended June 30, 2023. The decrease in cash flow for the period year-over-year was driven mainly by the net impact of timing differences in government receivables and payables, including Medicare and Medicaid prepayments, risk corridor settlement activity, and timing differences in receipts and payments of provider payables.

2024 Guidance

Premium revenue for the full year is expected to be approximately $38 billion, an increase of approximately 17% from the full year 2023.

The Company reaffirms its full year adjusted earnings per diluted share in 2024 to be at least $23.50, representing approximately 13% growth over the full year 2023. The Medicaid pressure experienced in the second quarter of 2024 is expected to be offset by higher net investment income and the extension of Virginia and Florida contracts in the second half of the year. The Company’s known rate adjustments in the second half of the year are expected to largely offset higher expected trend in the second half of the year.

Conference Call

Management will host a conference call and webcast to discuss Molina Healthcare’s second quarter results at 8:00 a.m. Eastern Time on Thursday, July 25, 2024. The number to call for the interactive teleconference is (877) 883-0383 and the confirmation number is 8508329. A telephonic replay of the conference call will be available through Thursday, August 1, 2024, by dialing (877) 344-7529 and entering confirmation number 5266367. A live audio broadcast of this conference call will be available on Molina Healthcare’s website, molinahealthcare.com. A 30-day online replay will be available approximately an hour following the conclusion of the live broadcast.

About Molina Healthcare

Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. For more information about Molina Healthcare, please visit molinahealthcare.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This earnings release and the Company’s accompanying oral remarks contain forward-looking statements. The Company intends such forward-looking statements to be covered under the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements provide current expectations of future events based on certain assumptions, and all statements other than statements of historical fact contained in this earnings release and the Company’s accompanying oral remarks may be forward-looking statements. In some cases, you can identify forward-looking statements by words such as “guidance,” “future,” “anticipates,” “believes,” “embedded,” “estimates,” “expects,” “growth,” “intends,” “plans,” “predicts,” “projects,” “will,” “would,” “could,” “can,” “may,” or the negative of these terms or other similar expressions. Forward-looking statements contained in this earnings release include, but are not limited to, statements regarding our business and financial performance, 2024 guidance and long-term targets, expected headwinds, normal and off-cycle Medicaid rate adjustments, and management’s plans and objectives for future operations and business strategy.

Actual results could differ materially due to numerous known and unknown risks and uncertainties. These risks and uncertainties are discussed under the headings “Forward-Looking Statements,” and “Risk Factors,” in the Company’s Annual Report on Form 10‑K for the year ended December 31, 2023, which is on file with the U.S. Securities and Exchange Commission (the “SEC”), and in the Company’s other filings with the SEC, including its Quarterly Report on Form 10-Q for the period ended June 30, 2024, to be filed with the SEC.

These reports can be accessed under the investor relations tab of the Company’s website or on the SEC’s website at sec.gov. Given these risks and uncertainties, the Company can give no assurances that its forward-looking statements will prove to be accurate, or that any other results or developments projected or contemplated by its forward-looking statements will in fact occur, and the Company cautions investors not to place undue reliance on these statements. All forward-looking statements in this release represent the Company’s judgment as of July 24, 2024, and, except as otherwise required by law, the Company disclaims any obligation to update any forward-looking statement to conform the statement to actual results or changes in its expectations.

 

MOLINA HEALTHCARE, INC.

UNAUDITED CONSOLIDATED STATEMENTS OF INCOME

 

 

Three Months Ended

 

Six Months Ended

 

June 30,

 

June 30,

 

2024

 

2023

 

2024

 

2023

 

 

 

 

 

 

 

 

 

(In millions, except per-share amounts)

Revenue:

 

 

 

 

 

 

 

Premium revenue

$

9,446

 

$

8,042

 

$

18,950

 

$

15,927

Premium tax revenue

 

298

 

 

169

 

 

595

 

 

341

Investment income

 

115

 

 

97

 

 

223

 

 

168

Other revenue

 

21

 

 

19

 

 

43

 

 

40

Total revenue

 

9,880

 

 

8,327

 

 

19,811

 

 

16,476

Operating expenses:

 

 

 

 

 

 

 

Medical care costs

 

8,368

 

 

7,038

 

 

16,782

 

 

13,909

General and administrative expenses

 

691

 

 

618

 

 

1,402

 

 

1,209

Premium tax expenses

 

298

 

 

169

 

 

595

 

 

341

Depreciation and amortization

 

46

 

 

42

 

 

91

 

 

86

Other

 

43

 

 

17

 

 

81

 

 

33

Total operating expenses

 

9,446

 

 

7,884

 

 

18,951

 

 

15,578

Operating income

 

434

 

 

443

 

 

860

 

 

898

Interest expense

 

28

 

 

27

 

 

55

 

 

55

Income before income tax expense

 

406

 

 

416

 

 

805

 

 

843

Income tax expense

 

105

 

 

107

 

 

203

 

 

213

Net income

$

301

 

$

309

 

$

602

 

$

630

 

 

 

 

 

 

 

 

Net income per share – Diluted

$

5.17

 

$

5.35

 

$

10.33

 

$

10.87

 

 

 

 

 

 

 

 

Diluted weighted average shares outstanding

 

58.2

 

 

57.9

 

 

58.3

 

 

58.0

 
 

MOLINA HEALTHCARE, INC.

CONSOLIDATED BALANCE SHEETS

 

 

June 30,

 

December 31,

 

2024

 

2023

 

Unaudited

 

 

 

(Dollars in millions,

except per-share amounts)

ASSETS

Current assets:

 

 

 

Cash and cash equivalents

$

4,354

 

 

$

4,848

 

Investments

 

4,347

 

 

 

4,259

 

Receivables

 

3,231

 

 

 

3,104

 

Prepaid expenses and other current assets

 

399

 

 

 

331

 

Total current assets

 

12,331

 

 

 

12,542

 

Property, equipment, and capitalized software, net

 

305

 

 

 

270

 

Goodwill and intangible assets, net

 

1,913

 

 

 

1,449

 

Restricted investments

 

268

 

 

 

261

 

Deferred income taxes, net

 

232

 

 

 

227

 

Other assets

 

136

 

 

 

143

 

Total assets

$

15,185

 

 

$

14,892

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

 

 

 

Medical claims and benefits payable

$

4,577

 

 

$

4,204

 

Amounts due government agencies

 

2,273

 

 

 

2,294

 

Accounts payable, accrued liabilities and other

 

973

 

 

 

1,252

 

Deferred revenue

 

13

 

 

 

418

 

Total current liabilities

 

7,836

 

 

 

8,168

 

Long-term debt

 

2,181

 

 

 

2,180

 

Finance lease liabilities

 

203

 

 

 

205

 

Other long-term liabilities

 

122

 

 

 

124

 

Total liabilities

 

10,342

 

 

 

10,677

 

Stockholders’ equity:

 

 

 

Common stock, $0.001 par value, 150 million shares authorized; outstanding: 59 million shares at June 30, 2024, and 58 million at December 31, 2023

 

 

 

 

 

Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding

 

 

 

 

 

Additional paid-in capital

 

439

 

 

 

410

 

Accumulated other comprehensive loss

 

(85

)

 

 

(82

)

Retained earnings

 

4,489

 

 

 

3,887

 

Total stockholders’ equity

 

4,843

 

 

 

4,215

 

Total liabilities and stockholders’ equity

$

15,185

 

 

$

14,892

 

 

 

 

 

 

MOLINA HEALTHCARE, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

 

Six Months Ended

 

June 30,

 

2024

 

2023

 

 

 

 

 

(In millions)

Operating activities:

 

 

 

Net income

$

602

 

 

$

630

 

Adjustments to reconcile net income to net cash (used in) provided by operating activities:

 

 

 

Depreciation and amortization

 

91

 

 

 

86

 

Deferred income taxes

 

21

 

 

 

(4

)

Share-based compensation

 

68

 

 

 

55

 

Other, net

 

4

 

 

 

5

 

Changes in operating assets and liabilities:

 

 

 

Receivables

 

(5

)

 

 

(83

)

Prepaid expenses and other current assets

 

16

 

 

 

6

 

Medical claims and benefits payable

 

(48

)

 

 

149

 

Amounts due government agencies

 

(43

)

 

 

510

 

Accounts payable, accrued liabilities and other

 

(307

)

 

 

(208

)

Deferred revenue

 

(405

)

 

 

55

 

Income taxes

 

1

 

 

 

202

 

Net cash (used in) provided by operating activities

 

(5

)

 

 

1,403

 

Investing activities:

 

 

 

Purchases of investments

 

(594

)

 

 

(924

)

Proceeds from sales and maturities of investments

 

506

 

 

 

546

 

Net cash paid in business combinations

 

(295

)

 

 

 

Purchases of property, equipment, and capitalized software

 

(54

)

 

 

(63

)

Other, net

 

2

 

 

 

2

 

Net cash used in investing activities

 

(435

)

 

 

(439

)

Financing activities:

 

 

 

Common stock withheld to settle employee tax obligations

 

(56

)

 

 

(59

)

Other, net

 

6

 

 

 

4

 

Net cash used in financing activities

 

(50

)

 

 

(55

)

Net (decrease) increase in cash, cash equivalents, and restricted cash and cash equivalents

 

(490

)

 

 

909

 

Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period

 

4,908

 

 

 

4,048

 

Cash, cash equivalents, and restricted cash and cash equivalents at end of period

$

4,418

 

 

$

4,957

 

 

 

 

 

MOLINA HEALTHCARE, INC.

UNAUDITED SEGMENT DATA

(Dollars in millions)

 

 

 

June 30,

 

December 31,

 

June 30,

 

 

2024

 

2023

 

2023

Ending Membership by Segment:

 

 

 

 

 

Medicaid

4,942,000

 

4,542,000

 

4,741,000

Medicare

251,000

 

172,000

 

166,000

Marketplace

386,000

 

281,000

 

269,000

Total

5,579,000

 

4,995,000

 

5,176,000

 

 

 

 

 

 

 

 

Three Months Ended June 30,

 

2024

 

2023

 

Premium

Revenue

 

Medical

Margin

 

MCR (1)

 

Premium

Revenue

 

Medical

Margin

 

MCR (1)

 

 

 

 

 

 

Medicaid

$

7,378

 

$

683

 

90.8

%

 

$

6,485

 

$

756

 

88.3

%

Medicare

 

1,441

 

 

217

 

84.9

 

 

 

1,044

 

 

113

 

89.2

 

Marketplace

 

627

 

 

178

 

71.6

 

 

 

513

 

 

135

 

73.7

 

Consolidated

$

9,446

 

$

1,078

 

88.6

%

 

$

8,042

 

$

1,004

 

87.5

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended June 30,

 

2024

 

2023

 

Premium

Revenue

 

Medical

Margin

 

MCR (1)

 

Premium

Revenue

 

Medical

Margin

 

MCR (1)

 

 

 

 

 

 

Medicaid

$

14,870

 

$

1,458

 

90.2

%

 

$

12,834

 

$

1,490

 

88.4

%

Medicare

 

2,883

 

 

380

 

86.8

 

 

 

2,090

 

 

239

 

88.6

 

Marketplace

 

1,197

 

 

330

 

72.4

 

 

 

1,003

 

 

289

 

71.2

 

Consolidated

$

18,950

 

$

2,168

 

88.6

%

 

$

15,927

 

$

2,018

 

87.3

%

_____________

(1)

The MCR represents medical costs as a percentage of premium revenue.

 

MOLINA HEALTHCARE, INC.

CHANGE IN MEDICAL CLAIMS AND BENEFITS PAYABLE

(Dollars in millions)

 

The Company’s claims liabilities include additional reserves to account for moderately adverse conditions based on historical experience and other factors including, but not limited to, variations in claims payment patterns, changes in utilization and cost trends, known outbreaks of disease, and large claims. The Company’s reserving methodology is consistently applied across all periods presented. The amounts displayed for “Components of medical care costs related to: Prior year” represent the amounts by which the original estimates of claims and benefits payable at the beginning of the year were more than the actual liabilities based on information (principally the payment of claims) developed since those liabilities were first reported. The following table presents the components of the change in medical claims and benefits payable for the periods indicated:

 

 

Six Months Ended

 

June 30,

 

2024

 

2023

 

 

 

 

 

Unaudited

Medical claims and benefits payable, beginning balance

$

4,204

 

 

$

3,528

 

Components of medical care costs related to:

 

 

 

Current year

 

17,301

 

 

 

14,180

 

Prior year

 

(519

)

 

 

(271

)

Total medical care costs

 

16,782

 

 

 

13,909

 

Payments for medical care costs related to:

 

 

 

Current year

 

13,429

 

 

 

11,166

 

Prior year

 

3,161

 

 

 

2,650

 

Total paid

 

16,590

 

 

 

13,816

 

Acquired balances, net of post-acquisition adjustments

 

421

 

 

 

 

Change in non-risk and other payables

 

(240

)

 

 

56

 

Medical claims and benefits payable, ending balance

$

4,577

 

 

$

3,677

 

 

 

 

 

Days in Claims Payable (1)

 

50

 

 

 

47

 

__________________

(1)

The Company calculates Days in Claims Payable using claims incurred but not paid, or IBNP, and other fee-for-service payables included in medical claims and benefits payable, and quarterly fee-for-service related costs included in medical care costs within the Company’s consolidated financial statements.

MOLINA HEALTHCARE, INC.

RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES

(In millions, except per diluted share amounts)

 

The Company believes that certain non-GAAP (generally accepted accounting principles) financial measures are useful supplemental measures to investors in comparing the Company’s performance to the performance of other public companies in the health care industry. The non-GAAP financial measures are also used internally to enable management to assess the Company’s performance consistently over time. These non-GAAP financial measures, presented below, should be considered as supplements to, and not as substitutes for or superior to, GAAP measures.

 

Adjustments represent additions and deductions to GAAP net income as indicated in the table below, which include the non-cash impact of amortization of acquired intangible assets, acquisition-related expenses, and the impact of certain expenses and other items that management believes are not indicative of longer-term business trends and operations.

 

Adjusted G&A Ratio represents the GAAP G&A ratio, recognizing adjustments.

 

Adjusted net income represents GAAP net income recognizing the adjustments, net of tax. The Company believes that adjusted net income is helpful to investors in assessing the Company’s financial performance.

 

Adjusted net income per diluted share represents adjusted net income divided by weighted average common shares outstanding on a fully diluted basis.

 

Adjusted after-tax margin represents adjusted net income, divided by total revenue.

 

Three Months Ended June 30,

 

Six Months Ended June 30,

2024

 

2023

 

2024

 

2023

 

Amount

 

Per

Diluted

Share

 

Amount

 

Per

Diluted

Share

 

Amount

 

Per

Diluted

Share

 

Amount

 

Per

Diluted

Share

GAAP Net income

$

301

 

 

$

5.17

 

 

$

309

 

 

$

5.35

 

 

$

602

 

 

$

10.33

 

 

$

630

 

 

$

10.87

 

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization of intangible assets

$

21

 

 

$

0.36

 

 

$

22

 

 

$

0.36

 

 

$

41

 

 

$

0.71

 

 

$

43

 

 

$

0.73

 

Acquisition-related expenses (1)

 

18

 

 

 

0.31

 

 

 

2

 

 

 

0.03

 

 

 

35

 

 

 

0.60

 

 

 

2

 

 

 

0.03

 

Other (2)

 

14

 

 

 

0.24

 

 

 

 

 

 

 

 

 

20

 

 

 

0.35

 

 

 

 

 

 

 

Subtotal, adjustments

 

53

 

 

 

0.91

 

 

 

24

 

 

 

0.39

 

 

 

96

 

 

 

1.66

 

 

 

45

 

 

 

0.76

 

Income tax effect

 

(13

)

 

 

(0.22

)

 

 

(6

)

 

 

(0.09

)

 

 

(23

)

 

 

(0.40

)

 

 

(11

)

 

 

(0.18

)

Adjustments, net of tax

 

40

 

 

 

0.69

 

 

 

18

 

 

 

0.30

 

 

 

73

 

 

 

1.26

 

 

 

34

 

 

 

0.58

 

Adjusted net income

$

341

 

 

$

5.86

 

 

$

327

 

 

$

5.65

 

 

$

675

 

 

$

11.59

 

 

$

664

 

 

$

11.45

 

__________________

(1)

Reflects non-recurring costs associated with acquisitions, including various transaction and certain integration costs.

(2)

The six months ended June 30, 2024 includes non-recurring litigation costs and one-time termination benefits.

 

MOLINA HEALTHCARE, INC.

RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES (CONTINUED)

2024 GUIDANCE

 

 

Amount

 

Per

Diluted

Share (2)

GAAP Net income

$

1,256

 

 

$

21.62

 

Adjustments:

 

 

 

Amortization of intangible assets

 

83

 

 

 

1.42

 

Acquisition-related expenses

 

44

 

 

 

0.75

 

Other

 

20

 

 

 

0.35

 

Subtotal, adjustments

 

147

 

 

 

2.52

 

Income tax effect (1)

 

(38

)

 

 

(0.64

)

Adjustments, net of tax

 

109

 

 

 

1.88

 

Adjusted net income

$

1,365

 

 

$

23.50

 

__________________

(1)

Income tax effect calculated at the statutory tax rate of approximately 23.9%.

(2)

Computations assume approximately 58.1 million diluted weighted average shares outstanding.

 

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.